Comparison of Capability and Health-related Quality of Life Instruments in Capturing Aspects of Mental Well-being in People with Schizophrenia and Depression
Overview
Affiliations
Background: There is increasing evidence that assessing outcomes in terms of capability provides information beyond that of health-related quality of life (HRQoL) for outcome evaluation in mental health research and clinical practice.
Aims: To assess similarities and differences in the measurement properties of the ICECAP-A capability measure and Oxford Capabilities Questionnaire for Mental Health (OxCAP-MH) in people with schizophrenia experiencing depression, and compare these measurement properties with those of (a) the EuroQol EQ-5D-5L and EuroQol Visual Analogue Scale (EQ-VAS) and (b) mental health-specific (disease-specific) measures.
Method: Using data for 100 patients from the UK, measurement properties were compared using correlation analyses, Bland-Altman plots and exploratory factor analysis. Responsiveness was assessed by defining groups who worsened, improved or remained unchanged, based on whether there was a clinically meaningful change in the instrument scores between baseline and 9-month follow-up assessments.
Results: The two capability instruments had stronger convergent validity with each other (Spearman's rho = 0.677) than with the HRQoL (rho = 0.354-0.431) or the mental health-specific (rho = 0.481-0.718) instruments. The OxCAP-MH tended to have stronger correlations with mental health-specific instruments than the ICECAP-A, whereas the ICECAP-A had slightly stronger correlation with the EQ-VAS. Change scores on the capability instruments correlated weakly with change scores on the HRQoL scales (rho = 0.131-0.269), but moderately with those on mental health-specific instruments for the ICECAP-A (rho = 0.355-0.451) and moderately/strongly on the OxCAP-MH (rho = 0.437-0.557).
Conclusions: Assessing outcomes in terms of capabilities for people with schizophrenia and depression provided more relevant, mental health-specific information than the EQ-5D-5L or the EQ-VAS. The ICECAP-A and the OxCAP-MH demonstrated similar psychometric properties, but the OxCAP-MH was more correlated with disease-specific instruments.
Shi Z, Cao A, Li S, Wang J, Zhang J, Ratcliffe J Health Qual Life Outcomes. 2024; 22(1):41.
PMID: 38816861 PMC: 11140898. DOI: 10.1186/s12955-024-02258-7.
Population normative data for OxCAP-MH capability scores.
Balazs P, Laszewska A, Simon J, Brodszky V Eur J Health Econ. 2024; 26(2):223-231.
PMID: 38789619 PMC: 11889034. DOI: 10.1007/s10198-024-01696-w.
Bogaert B, Kozlakidis Z, Caboux E, Peron J, Saintingy P PLOS Glob Public Health. 2023; 3(9):e0002366.
PMID: 37747872 PMC: 10519589. DOI: 10.1371/journal.pgph.0002366.
Shi Z, Nie H, Geng L, Wang X, Chen G, Li S Qual Life Res. 2023; 32(5):1469-1480.
PMID: 36617607 DOI: 10.1007/s11136-022-03330-9.
Kinchin I, Leroi I, Kennelly S, Kochovska S, Brady C, Fitzhenry D Front Aging Neurosci. 2023; 14:1061247.
PMID: 36589541 PMC: 9800871. DOI: 10.3389/fnagi.2022.1061247.